Abbott Net Debt from 2010 to 2025

ABT Stock

USD 126.34 0.44 0.35%

Abbott Laboratories Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt will likely drop to about 6.1 B in 2025. Net Debt is the total debt of Abbott Laboratories minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1985-12-31

Previous Quarter

7.4 B

Current Value

7.4 B

Quarterly Volatility

5.1 B

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 531 M or Selling General Administrative of 6.4 B, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0186 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.

Check out the analysis of Abbott Laboratories Correlation against competitors.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Latest Abbott Laboratories' Net Debt Growth Pattern

Below is the plot of the Net Debt of Abbott Laboratories over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Abbott Laboratories' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Abbott Net Debt Regression Statistics

	Arithmetic Mean	8,393,622,855
	Geometric Mean	5,995,133,070
	Coefficient Of Variation	60.83
	Mean Deviation	3,924,321,895
	Median	8,601,757,000
	Standard Deviation	5,105,635,905
	Sample Variance	26067518T
	Range	18.4B
	R-Value	0.31
	Mean Square Error	25299893.1T
	R-Squared	0.09
	Significance	0.25
	Slope	329,055,093
	Total Sum of Squares	391012769.9T

Abbott Net Debt History

	2025	6.1 B
	2024	7.4 B
	2023	9 B
	2022	7.8 B
	2021	9.2 B
	2020	12.8 B
	2019	15 B

Other Fundumenentals of Abbott Laboratories

Net Debt To E B I T D A

Abbott Laboratories Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Short Term Investments	Common Stock	Intangible Assets	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Long Term Debt Total	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	0.65	0.82	0.86	0.79	0.6	-0.13	0.84	-0.68	-0.13	-0.01	0.61	0.7	-0.69	0.84	0.84	-0.09	0.58	-0.22	-0.53	0.37	-0.69	-0.27	-0.36	0.58
Total Stockholder Equity	0.92		0.4	0.95	0.88	0.51	0.42	-0.05	0.88	-0.73	-0.14	-0.12	0.38	0.4	-0.69	0.81	0.73	0.17	0.34	-0.21	-0.52	0.43	-0.67	-0.14	-0.34	0.79
Net Debt	0.65	0.4		0.17	0.36	0.8	0.25	-0.42	0.46	-0.28	-0.19	0.01	0.97	0.8	-0.37	0.53	0.83	-0.71	0.7	-0.27	-0.2	-0.03	-0.72	-0.57	-0.58	-0.04
Retained Earnings	0.82	0.95	0.17		0.82	0.36	0.4	0.07	0.79	-0.73	-0.17	-0.17	0.14	0.27	-0.71	0.7	0.54	0.38	0.21	-0.01	-0.43	0.5	-0.51	0.02	-0.21	0.83
Net Receivables	0.86	0.88	0.36	0.82		0.53	0.51	0.06	0.73	-0.42	0.05	0.22	0.29	0.37	-0.34	0.81	0.62	0.12	0.33	-0.33	-0.68	0.27	-0.46	0.03	-0.19	0.7
Total Liab	0.79	0.51	0.8	0.36	0.53		0.75	-0.21	0.55	-0.43	-0.06	0.12	0.74	0.88	-0.53	0.71	0.81	-0.41	0.69	-0.2	-0.36	0.21	-0.49	-0.41	-0.29	0.0
Total Current Assets	0.6	0.42	0.25	0.4	0.51	0.75		0.19	0.32	-0.37	0.34	0.16	0.15	0.55	-0.38	0.55	0.39	0.1	0.34	-0.15	-0.35	0.3	0.04	0.03	0.17	0.02
Short Term Debt	-0.13	-0.05	-0.42	0.07	0.06	-0.21	0.19		-0.31	-0.06	0.43	0.33	-0.39	-0.5	0.08	-0.22	-0.37	0.4	-0.71	-0.06	0.21	0.02	0.56	0.41	0.4	-0.08
Accounts Payable	0.84	0.88	0.46	0.79	0.73	0.55	0.32	-0.31		-0.63	-0.36	-0.16	0.45	0.45	-0.66	0.88	0.84	0.1	0.43	-0.24	-0.7	0.49	-0.81	-0.46	-0.46	0.74
Current Deferred Revenue	-0.68	-0.73	-0.28	-0.73	-0.42	-0.43	-0.37	-0.06	-0.63		0.2	0.24	-0.35	-0.33	0.86	-0.48	-0.53	-0.21	-0.14	0.03	0.0	-0.42	0.54	0.31	0.34	-0.45
Short Term Investments	-0.13	-0.14	-0.19	-0.17	0.05	-0.06	0.34	0.43	-0.36	0.2		0.07	-0.23	-0.22	0.35	-0.16	-0.27	0.15	-0.35	-0.27	0.04	-0.29	0.48	0.28	0.32	-0.28
Common Stock	-0.01	-0.12	0.01	-0.17	0.22	0.12	0.16	0.33	-0.16	0.24	0.07		0.0	-0.05	0.43	0.05	-0.05	-0.15	-0.11	-0.18	-0.18	-0.16	0.28	0.16	0.18	-0.17
Intangible Assets	0.61	0.38	0.97	0.14	0.29	0.74	0.15	-0.39	0.45	-0.35	-0.23	0.0		0.75	-0.41	0.44	0.79	-0.75	0.64	-0.25	-0.11	-0.05	-0.74	-0.61	-0.56	-0.03
Long Term Debt	0.7	0.4	0.8	0.27	0.37	0.88	0.55	-0.5	0.45	-0.33	-0.22	-0.05	0.75		-0.48	0.49	0.67	-0.53	0.92	-0.01	-0.21	0.17	-0.53	-0.35	-0.29	0.03
Treasury Stock	-0.69	-0.69	-0.37	-0.71	-0.34	-0.53	-0.38	0.08	-0.66	0.86	0.35	0.43	-0.41	-0.48		-0.49	-0.6	-0.08	-0.3	-0.26	0.03	-0.44	0.57	0.36	0.33	-0.4
Property Plant Equipment	0.84	0.81	0.53	0.7	0.81	0.71	0.55	-0.22	0.88	-0.48	-0.16	0.05	0.44	0.49	-0.49		0.88	0.03	0.45	-0.37	-0.75	0.41	-0.64	-0.31	-0.36	0.52
Good Will	0.84	0.73	0.83	0.54	0.62	0.81	0.39	-0.37	0.84	-0.53	-0.27	-0.05	0.79	0.67	-0.6	0.88		-0.32	0.58	-0.35	-0.54	0.28	-0.83	-0.58	-0.56	0.34
Net Tangible Assets	-0.09	0.17	-0.71	0.38	0.12	-0.41	0.1	0.4	0.1	-0.21	0.15	-0.15	-0.75	-0.53	-0.08	0.03	-0.32		-0.51	0.14	-0.18	0.44	0.28	0.28	0.21	0.45
Long Term Debt Total	0.58	0.34	0.7	0.21	0.33	0.69	0.34	-0.71	0.43	-0.14	-0.35	-0.11	0.64	0.92	-0.3	0.45	0.58	-0.51		-0.01	-0.3	0.19	-0.55	-0.25	-0.27	0.13
Long Term Investments	-0.22	-0.21	-0.27	-0.01	-0.33	-0.2	-0.15	-0.06	-0.24	0.03	-0.27	-0.18	-0.25	-0.01	-0.26	-0.37	-0.35	0.14	-0.01		0.44	0.05	0.2	0.15	0.13	-0.09
Accumulated Depreciation	-0.53	-0.52	-0.2	-0.43	-0.68	-0.36	-0.35	0.21	-0.7	0.0	0.04	-0.18	-0.11	-0.21	0.03	-0.75	-0.54	-0.18	-0.3	0.44		-0.33	0.37	0.22	0.15	-0.57
Short Long Term Debt	0.37	0.43	-0.03	0.5	0.27	0.21	0.3	0.02	0.49	-0.42	-0.29	-0.16	-0.05	0.17	-0.44	0.41	0.28	0.44	0.19	0.05	-0.33		-0.28	-0.07	-0.17	0.45
Cash And Equivalents	-0.69	-0.67	-0.72	-0.51	-0.46	-0.49	0.04	0.56	-0.81	0.54	0.48	0.28	-0.74	-0.53	0.57	-0.64	-0.83	0.28	-0.55	0.2	0.37	-0.28		0.67	0.8	-0.49
Net Invested Capital	-0.27	-0.14	-0.57	0.02	0.03	-0.41	0.03	0.41	-0.46	0.31	0.28	0.16	-0.61	-0.35	0.36	-0.31	-0.58	0.28	-0.25	0.15	0.22	-0.07	0.67		0.78	0.05
Net Working Capital	-0.36	-0.34	-0.58	-0.21	-0.19	-0.29	0.17	0.4	-0.46	0.34	0.32	0.18	-0.56	-0.29	0.33	-0.36	-0.56	0.21	-0.27	0.13	0.15	-0.17	0.8	0.78		-0.16
Capital Stock	0.58	0.79	-0.04	0.83	0.7	0.0	0.02	-0.08	0.74	-0.45	-0.28	-0.17	-0.03	0.03	-0.4	0.52	0.34	0.45	0.13	-0.09	-0.57	0.45	-0.49	0.05	-0.16

Click cells to compare fundamentals

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	7.4 B	6.1 B
Net Debt To EBITDA	0.68	0.77

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abbott Net Debt from 2010 to 2025

Latest Abbott Laboratories' Net Debt Growth Pattern

Abbott Net Debt Regression Statistics

Abbott Net Debt History

Other Fundumenentals of Abbott Laboratories

Abbott Laboratories Net Debt component correlations

About Abbott Laboratories Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Abbott Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY